Impact of Sulfatase‐2 on cancer progression and prognosis in patients with renal cell carcinomaShin Kumagai(Fukushima Medical University), Yoshiyuki Kojima(Fukushima Medical University)Cancer ScienceSeptember 2, 201610.1111/cas.13074Cited by 14SaveCiteExport RISWatch citationsRelated PapersOverriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade|Oncotarget|2017|55l-Theanine Protects Bladder Function by Suppressing Chronic Sympathetic Hyperactivity in Spontaneously Hypertensive Rat|Metabolites|2021|11Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat|International Journal of Molecular Sciences|2023|7